1
|
Luigi R, Stefania S, Francesca I, Federica R, Fiore BD, Annalisa S, Francesco DG, Eugenio M, Mandorino M, Adriana M, Eleonora S, Carmela DC, Lucia N, Enrica R, Michele M, Maria Teresa M, Raffaele DP. HPV and Covid-19 Era: effects of nonpharmaceutical interventions on HPV transmission. Pathog Glob Health 2023; 117:735-743. [PMID: 37533358 PMCID: PMC10614711 DOI: 10.1080/20477724.2023.2239052] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 08/04/2023] Open
Abstract
Human papillomavirus (HPV) is considered the commonest viral cause of sexually transmitted infections. The impact of social distance measures due to Covid-19 pandemic on HPV spread is unknown. Therefore, this study has analyzed the seven-year trend of HPV prevalence in all patients tested for HPV DNA at the Microbiology and Virology Unit at Bari Policlinico. Moreover, the HPV prevalence in 2020 has been compared with the previous year ones in order to evaluate the consequences of lockdown and social distancing measures on transmission risks. From 2013 to 2020, we retrospectively analyzed 64 anal swabs, 418 biopsies, 5925 cervical-vaginal swabs, 512 cervical swabs, 104 gland swabs, 154 oral swabs, 21 seminal fluids and 503 urethral swabs. HPV DNA detection was initially performed using nested-polymerase chain reaction (PCR) and subsequently multiplex real-time PCR assay. All statistical tests were carried out by the open-source environment R 4.0.3 (R Core Team). The data were analyzed according to yearly positivity rates, temporal trend and prevalence of HPV genotypes (HPV-6, HPV-11, HPV-16, HPV-18, high risk and low risk) by age category and sex. The number of patients increased steadily from 2016 to 2019 and then decreased in 2020. There were significant differences in prevalence between females and males for HPV-6 (6.16% in females Vs 30.80% in males), HPV-11 (0.82% Vs 7.16%) and HPV-16 (7.77% Vs 5.01%). The prevalence of HPV-6 and HPV-11 significantly increased in 2020 compared to 2013-2019 (15.72% Vs 8.52 and 3.18% Vs 1.44%). On the contrary, the overall prevalence of HPV DNA remained constant in 2020 (52.84% Vs 48.44%). Over time, the prevalence of HPV DNA (Coefficient=-0.020, p-value = 0.036) and particularly high-risk genotypes (Coefficient=-0.030, p-value = 0.005) decreased in females, while low-risk genotypes (Coefficient = 0.141, p-value= < 0.001) and the prevalence of HPV DNA increased in males (Coefficient = 0.068, p-value = 0.008). During the pandemic, the number of screened patients declined, although HPV prevalence compared to 2013-2019 remained constant or increased as in the case of low-risk genotypes. It can be assumed that the reduction of the screening coverage favored the emerging of the more symptomatic low-risk infections. In conclusion, nonpharmaceutical interventions due to Covid-19 pandemic did not reduce the risk of HPV infection but it likely caused a decrease in access to health services resulting in an increased risk of undiagnosed HPV.
Collapse
Affiliation(s)
- Ronga Luigi
- Microbiology and Virology, UOC, Azienda Ospedaliero-Universitaria Policlinico, Bari, Italy
| | - Stolfa Stefania
- Microbiology Section, Medicine Interdisciplinary Department, Medicine School, Bari “Aldo Moro” University, Bari, Italy
| | - Indraccolo Francesca
- Microbiology Section, Medicine Interdisciplinary Department, Medicine School, Bari “Aldo Moro” University, Bari, Italy
| | - Romanelli Federica
- Microbiology Section, Medicine Interdisciplinary Department, Medicine School, Bari “Aldo Moro” University, Bari, Italy
| | - Bavaro Davide Fiore
- Clinic of Infectious Diseases, Department of Biomedical Sciences and Human Oncology, Bari “Aldo Moro” University, Bari, Italy
| | - Saracino Annalisa
- Clinic of Infectious Diseases, Department of Biomedical Sciences and Human Oncology, Bari “Aldo Moro” University, Bari, Italy
| | - Di Gennaro Francesco
- Clinic of Infectious Diseases, Department of Biomedical Sciences and Human Oncology, Bari “Aldo Moro” University, Bari, Italy
| | - Milano Eugenio
- Clinic of Infectious Diseases, Department of Biomedical Sciences and Human Oncology, Bari “Aldo Moro” University, Bari, Italy
| | - Manuela Mandorino
- Microbiology Section, Medicine Interdisciplinary Department, Medicine School, Bari “Aldo Moro” University, Bari, Italy
| | - Mosca Adriana
- Microbiology Section, Medicine Interdisciplinary Department, Medicine School, Bari “Aldo Moro” University, Bari, Italy
| | - Sparapano Eleonora
- Microbiology and Virology, UOC, Azienda Ospedaliero-Universitaria Policlinico, Bari, Italy
| | - De Carlo Carmela
- Microbiology and Virology, UOC, Azienda Ospedaliero-Universitaria Policlinico, Bari, Italy
| | - Nisi Lucia
- Microbiology and Virology, UOC, Azienda Ospedaliero-Universitaria Policlinico, Bari, Italy
| | - Ranieri Enrica
- Microbiology Section, Medicine Interdisciplinary Department, Medicine School, Bari “Aldo Moro” University, Bari, Italy
| | - Mastria Michele
- Microbiology Section, Medicine Interdisciplinary Department, Medicine School, Bari “Aldo Moro” University, Bari, Italy
| | - Montagna Maria Teresa
- Hygiene Section, Medicine Interdisciplinary Department, Medicine School, Bari “Aldo Moro” University, Bari, Italy
| | - Del Prete Raffaele
- Microbiology Section, Medicine Interdisciplinary Department, Medicine School, Bari “Aldo Moro” University, Bari, Italy
| |
Collapse
|
2
|
Del Romero J, Moreno Guillén S, Rodríguez-Artalejo FJ, Ruiz-Galiana J, Cantón R, De Lucas Ramos P, García-Botella A, García-Lledó A, Hernández-Sampelayo T, Gómez-Pavón J, González Del Castillo J, Martín-Delgado MC, Martín Sánchez FJ, Martínez-Sellés M, Molero García JM, Gómez Castellá J, Palomo M, García Berrio R, Couso González A, Sotomayor C, Bouza E. Sexually transmitted infections in Spain: Current status. Rev Esp Quimioter 2023; 36:444-465. [PMID: 37335757 PMCID: PMC10586737 DOI: 10.37201/req/038.2023] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/06/2023] [Accepted: 05/30/2023] [Indexed: 06/21/2023]
Abstract
Sexually Transmitted Infections (STI) are a major public health problem. The problems inherent to their diagnosis, treatment and prevention have to do not only with their nature, but also with organizational issues and overlapping competencies of the different health authorities in Spain. The real situation of STI in Spain, at present, is poorly known. For this reason, the Scientific Committee on COVID and Emerging Pathogens of the Illustrious Official College of Physicians of Madrid (ICOMEM) has formulated a series of questions on this subject which were distributed, not only among the members of the Committee, but also among experts outside it. The central health authorities provide very high and increasing figures for gonococcal infection, syphilis, Chlamydia trachomatis infection and lymphogranuloma venereum (LGV). Both HIV infection and Monkeypox are two important STI caused by viruses in our environment, to which it should be added, mainly, Herpes simplex virus (HSV) and Human papillomavirus (HPV) infections. Emerging microorganisms such as Mycoplasma genitalium pose not only pathogenic challenges but also therapeutic problems, as in the case of N. gonohrroeae. The pathways that patients with suspected STI follow until they are adequately diagnosed and treated are not well known in Spain. Experts understand that this problem is fundamentally managed in public health institutions, and that Primary Care and Hospital Emergency Services, together with some institutions that deal monographically with this problem, are the recipients of most of these patients. One of the most serious difficulties of STI lies in the availability of the microbiological tests necessary for their diagnosis, particularly in this era of outsourcing of microbiology services. Added to this is the increased cost of implementing the latest generation of molecular techniques and the difficulties of transporting samples. It is clear that STI are not diseases to which the entire population is equally exposed and it is necessary to have a better knowledge of the risk groups where to focus the necessary interventions adapted to their characteristics. It should not be forgotten that STI are also a problem in the pediatric age group and that their presence can be a marker of sexual abuse with all that this implies in terms of health care and medicolegal activity. Finally, STI are infections that are associated with a high cost of care for which we have very little information. The possibility of expanding the automatic performance of laboratory tests for STI surveillance through laboratory routines is encountering ethical and legal problems that are not always easy to solve. Spain has created a ministerial area of specific attention to STI and there are plans to improve the diagnosis, treatment and prevention of these problems, but we still lack the necessary evidence on their impact. We cannot forget that these are diseases that transcend the individual and constitute a Public Health problem.
Collapse
Affiliation(s)
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | - E Bouza
- Servicio de Microbiología Clínica y Enfermedades Infecciosas del Hospital General Universitario Gregorio Marañón, Universidad Complutense. CIBERES. Ciber de Enfermedades Respiratorias. Madrid, Spain.
| |
Collapse
|
3
|
Martin-Gorgojo A, Menéndez-Orenga M, Comunión-Artieda A, Martín-Pozas R, Montero-Rivas P, Bru-Gorraiz FJ. SARS-CoV-2 infection in patients with or at risk for venereal infections: Incidence and associated factors in a sexual health clinic. Actas Dermosifiliogr 2023; 114:580-586. [PMID: 37088287 PMCID: PMC10122956 DOI: 10.1016/j.ad.2023.04.017] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/07/2023] [Revised: 03/14/2023] [Accepted: 04/02/2023] [Indexed: 04/25/2023] Open
Abstract
BACKGROUND AND OBJECTIVE SARS-CoV-2 is more easily spread by close contact, which is inherent to sexual intercourse. People with, or at risk for, sexually transmitted infections (STIs) may therefore have higher rates of COVID-19. The aim of this study was to estimate SARS-CoV-2 antibody seroprevalence in people seen at a dedicated STI clinic, compare our findings to the estimated seroprevalence in the local general population, and study factors associated with SARS-CoV-2 infection in this setting. MATERIAL AND METHODS Cross-sectional observational study including consecutive patients older than 18 years of age who had not yet been vaccinated against COVID-19 and who underwent examination or screening at a dedicated municipal STI clinic in March and April 2021. We ordered rapid SARS-CoV-2 serology and collected information on demographic, social, and sexual variables, STI diagnoses, and history of symptoms compatible with SARS-CoV-2 infection. RESULTS We studied 512 patients (37% women). Fourteen (24.2%) had a positive SARS-CoV-2 test. Variables associated with positivity were use of FFP2 masks (odds ratio 0.50) and a higher-than-average number of sexual partners (odds ratio 1.80). Use of FFP2 masks was not randomly distributed in this sample. CONCLUSIONS Sexually active members of the population in this study had a higher incidence of SARS-CoV-2 infection than the general population. The main route of infection in this group appears to be respiratory, linked to close contact during sexual encounters; sexual transmission of the virus is probably limited.
Collapse
Affiliation(s)
- A Martin-Gorgojo
- Servicio de Infecciones de Transmisión Sexual/Dermatología, Sección de Especialidades Médicas, Organismo Autónomo Madrid Salud, Ayuntamiento de Madrid, Madrid, España.
| | - M Menéndez-Orenga
- Centro de Salud La Ventilla, Servicio Madrileño de Salud, Instituto de Investigación Sanitaria del Hospital Universitario 12 de Octubre (IMAS12), Madrid, España
| | - A Comunión-Artieda
- Servicio de Infecciones de Transmisión Sexual/Dermatología, Sección de Especialidades Médicas, Organismo Autónomo Madrid Salud, Ayuntamiento de Madrid, Madrid, España
| | - R Martín-Pozas
- Servicio de Infecciones de Transmisión Sexual/Dermatología, Sección de Especialidades Médicas, Organismo Autónomo Madrid Salud, Ayuntamiento de Madrid, Madrid, España
| | - P Montero-Rivas
- Servicio de Farmacia, Organismo Autónomo Madrid Salud, Ayuntamiento de Madrid, Madrid, España
| | - F-J Bru-Gorraiz
- Servicio de Infecciones de Transmisión Sexual/Dermatología, Sección de Especialidades Médicas, Organismo Autónomo Madrid Salud, Ayuntamiento de Madrid, Madrid, España
| |
Collapse
|
4
|
Casanova-Esquembre A, Fuster Escrivá B, Lorca Spröhnle J, Labrandero-Hoyos C, Peñuelas-Leal R, Gimeno Cardona C, Pérez-Ferriols A, Hernández-Bel P. [Translated article] Epidemiologic Profile of the Main Bacterial Sexually Transmitted Infections During the SARS-CoV-2 Pandemic. Actas Dermosifiliogr 2023; 114:T108-T113. [PMID: 36462671 PMCID: PMC9710105 DOI: 10.1016/j.ad.2022.07.027] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/10/2022] [Accepted: 07/08/2022] [Indexed: 12/03/2022] Open
Abstract
BACKGROUND AND OBJECTIVE The COVID-19 pandemic brought about social changes in 2020 and 2021. The aim of this study was to evaluate the epidemiologic profiles of the main sexually transmitted infections (STIs) of bacterial origin (chlamydia, gonorrhea, and syphilis) diagnosed during this period and compare them to findings from previous years. MATERIAL AND METHODS Drawing on data from Hospital General Universitario in Valencia, Spain, we recorded the number of chlamydia, gonorrhea, and syphilis cases diagnosed monthly by multiplex polymerase chain reaction (PCR) in 2018-2021 and the number of PCR-confirmed SARS-CoV-2 cases diagnosed monthly in 2020-2021. We also collected clinical and demographic information on all patients diagnosed with STIs during the years studied. RESULTS The total number of STIs diagnosed increased from 570 in 2018-2019 to 664 in 2020-2021. PCR positivity rates were similar in the 2 periods, but the incidence rates were higher during the pandemic. The chronologic correlation between SARS-CoV-2 and STI positivity was negative. Mean age at diagnosis was 29.64 years (95% CI, 19.33-41.14 years) for chlamydia, 30.86 years (95% CI, 20.24-42.45 years) for gonorrhea, and 37.04 years (95% CI, 26.01-51.00 years) for syphilis. The number of men diagnosed with chlamydia increased by 13.85% (95% CI, 6.39-21.08; p=.0003) during the pandemic. CONCLUSIONS We observed a negative correlation between SARS-CoV2 infections and STIs during the pandemic and an increase in chlamydia cases among men. STI cases rose during 2020-2021, indicating that they remain a significant problem that needs to be addressed in young and adult populations.
Collapse
Affiliation(s)
- A. Casanova-Esquembre
- Servicio de Dermatología, Hospital General Universitario de Valencia, Spain,Corresponding author
| | - B. Fuster Escrivá
- Servicio de Microbiología, Hospital General Universitario de Valencia, Spain
| | - J. Lorca Spröhnle
- Servicio de Dermatología, Hospital General Universitario de Valencia, Spain
| | | | - R. Peñuelas-Leal
- Servicio de Dermatología, Hospital General Universitario de Valencia, Spain
| | - C. Gimeno Cardona
- Servicio de Microbiología, Hospital General Universitario de Valencia, Spain
| | - A. Pérez-Ferriols
- Servicio de Dermatología, Hospital General Universitario de Valencia, Spain
| | - P. Hernández-Bel
- Servicio de Dermatología, Hospital General Universitario de Valencia, Spain
| |
Collapse
|
5
|
Rezaeian A, Ahmadi Pishkuhi M, Oliveira Reis L, Aghamir SMK. Sexuality Transmitted Infection in the COVID-19 Pandemic and Non-Pandemic Time. Am J Mens Health 2022; 16:15579883221134900. [PMID: 36412243 PMCID: PMC9692181 DOI: 10.1177/15579883221134900] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022] Open
Abstract
On March 11, 2020, the World Health Organization recognized the SARS-CoV-2 infection as a pandemic. The pandemic itself in addition to its containment measures affects individuals' lifestyles and welfare including their sexual behaviors. Thus, we hypothesized that sexually transmitted infection (STI) incidence may be changed and so we evaluate urethritis incidence as the most common STI in men and some other related factors. Two cross-sectional surveys during the first 6 months of 2019 and 2020 were undertaken and data were collected from 11 urology offices located in different parts of the capital city. In total, 34,611 male participants were included in our study, and 191 (.55%) patients' clinical diagnoses were urethritis. The urethritis incidence significantly decreased from 149 of 17,950 (.83%) to 42 of 16,661 (.25%) individuals in the same period of the years 2019 and 2020, respectively (p-value < .001). There was a higher percentage of single (p-value = .049) and older (p-value < .001) urethritis patients in the first 6 months of the year 2020 compared with 2019. Our survey provided urethritis incidence, demographics, symptoms, and treatment characterization. As our results show, the proportion of urethritis patients in all populations admitted to urologist offices had dramatically decreased during the COVID-19 pandemic compared with prior. The indirect effects of the pandemic and its containment measures on people's sexual health should be noticed and an appropriate reaction and policy-making are recommended to manage issues properly in different aspects of sexual health.
Collapse
Affiliation(s)
- AhmadReza Rezaeian
- Faculty of Medicine, Shahid Beheshti
University of Medical Sciences, Tehran, Iran,Urology Research Center, Tehran
University of Medical Sciences, Tehran, Iran
| | - Mahin Ahmadi Pishkuhi
- Urology Research Center, Tehran
University of Medical Sciences, Tehran, Iran,Pars Advanced & Minimally Invasive
Medical Manners Research Center, Pars General Hospital, Iran University of Medical
Sciences, Tehran, Iran
| | - Leonardo Oliveira Reis
- UroScience and Department of Surgery
(Urology), School of Medical Sciences, University of Campinas, Unicamp, and
Pontifical Catholic University of Campinas (PUC-Campinas), Campinas, Brazil
| | - Seyed Mohammad Kazem Aghamir
- Urology Research Center, Tehran
University of Medical Sciences, Tehran, Iran,Seyed Mohammad Kazem Aghamir, Urology
Research Center, Sina Hospital, Tehran University of Medical Sciences, Hassan
Abad Sq., Imam Khomeini Ave., Tehran, Iran.
| |
Collapse
|
6
|
Yuguero Torres O, Fernandez J, Justribo E, González E, Vena A. Impact of the SARS-COV-2 Pandemic Lockdown on Sexually Transmitted Urethritis in a Spanish Health Region. Cureus 2021; 13:e18921. [PMID: 34812305 PMCID: PMC8603631 DOI: 10.7759/cureus.18921] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 10/20/2021] [Indexed: 11/05/2022] Open
Abstract
Background The incidence of sexually transmitted diseases (STD) has increased in recent years, especially in the young population. Urethritis is one of the most common clinical presentations of STD in emergency departments. During the SARS-COV-2 pandemic, in Spain lockdown lasted almost three months, and mobility was greatly restricted. This is the first study of these characteristics conducted in Spain. Methods A cross-sectional study of all patients treated for clinical symptoms of urethritis between March and June 2019 and between March and June 2020 was conducted. We evaluated patients' sociodemographic and clinical variables. Results Seventy-nine patients were included in the study: 37 in 2019 and 38 in 2020 of whom 94.9% were men. The main symptoms were urethral discharge (59.5%) followed by dysuria (26.6%). Risky sexual relations were reported by 63.2% of patients in 2019, and this percentage decreased to 43.9% in 2020. Conclusions The number of patients attending an emergency department in our health region for urethritis did not undergo any variations between 2019 and 2020. No significant reduction in the number of cases of urethritis was observed, probably because people continued with unsafe sexual relations despite the social restrictions and difficulties posed by the lockdown.
Collapse
Affiliation(s)
| | - Josep Fernandez
- Dermatology, Institut de Recerca Biomèdica de Lleida (IRBLLEIDA), Lleida, ESP
| | - Elena Justribo
- Primary Health, Institut Català de la Salut, Lleida, ESP
| | - Eva González
- Infectious Diseases, Institut de Recerca Biomèdica de Lleida (IRBLLEIDA), Lleida, ESP
| | - Ana Vena
- Geriatrics, Institut de Recerca Biomèdica de Lleida (IRBLLEIDA), Lleida, ESP
| |
Collapse
|